Siemens (SI) to Market BioPorto’s Breakthrough Kidney Test
12/11/2012 9:59:50 AM
Expectations for BioPorto Diagnostics have been high since the company launched its anticipated blockbuster product almost two years ago – the kidney injury test known as NGAL. Since then, BioPorto has worked towards solutions that would ensure broad and early market access to the test. In this regard, the first partnership on a global marketing level is now in place. This comes in the form of an informal sales partnership with Siemens Healthcare Diagnostics actively promoting BioPorto’s NGAL test, while the distribution still flows through BioPorto’s sales channels.
comments powered by